Medical Condition News

RSS

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

Independent drug action, not synergy nor additivity, accounted for the clinical efficacy of nearly all examined combination therapies involving immune checkpoint inhibitors in clinical trials, according to results from a retrospective analysis.

19 Jan 2022

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

New therapies for autoimmune rheumatic diseases (AIRDs) that are designed to better regulate lipid (fat) metabolism, could significantly reduce the harmful side-effects caused by conventional treatments, finds a new large-scale review led by UCL researchers.

19 Jan 2022

Antibody combination produces a synergistic response in difficult-to-treat pediatric cancers

A combination of anti-cancer antibodies produced a powerfully synergistic response in two hard-to-treat pediatric cancers, according to a new study, in mice, led by researchers at the Stanford University School of Medicine.

19 Jan 2022

Research reveals the impact of COVID-19 on youth with ADHD

Compared to their peers, youth with attention-deficit/hyperactivity disorder (ADHD) are more likely to experience significant impairment in school functioning and mental health. Mix in the COVID-19 pandemic and the disruptions are even greater.

18 Jan 2022

Partial bone marrow transplant can dramatically improve survival of mice with cystic fibrosis

Scientists at La Jolla Institute for Immunology have found they can dramatically improve survival of mice with cystic fibrosis through a partial bone marrow transplant.

18 Jan 2022

Machine learning model identifies new risk genes for motor neurone disease

Scientists have developed a new machine learning model for the discovery of genetic risk factors for diseases such as Motor Neurone Disease (MND).

18 Jan 2022

Rare genetic variants may raise risk of fatal arrhythmias in patients with less advanced coronary artery disease

Advanced coronary artery disease and the cardiac hypertrophy often associated with it is the most common cause of sudden cardiac death.

18 Jan 2022

Research provides new insights on memory loss in Alzheimer's disease

Members of the "Synaptic Dysfunction and Disease" group at the Institute of Biomedicine of Seville, led by researchers Francisco Gómez Scholl and Amalia Martínez Mir, recently published the results of their research into Alzheimer's disease.

18 Jan 2022

New MRI technique could pave the way to quicker assessment of multiple sclerosis

It is important that multiple sclerosis (MS) is diagnosed and treated as early as possible in order to delay progression of the disease.

18 Jan 2022

New pathways responsible for hepatocellular carcinoma identified

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer. It is one of leading causes of cancer-related deaths globally, with more than 700,000 new cases and 600,000 estimated HCC deaths each year.

18 Jan 2022

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Individuals living with type 1 diabetes must carefully follow prescribed insulin regimens every day, receiving injections of the hormone via syringe, insulin pump or some other device. And without viable long-term treatments, this course of treatment is a lifelong sentence.

18 Jan 2022

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

Among patients with no detectable coronary artery calcium, those who smoke, have diabetes or hypertension nonetheless have the highest risk of cardiovascular disease events, according to a study published in the journal Circulation.

18 Jan 2022

NIH launches first phase of the Neuromod Prize to develop new neuromodulation therapies

The National Institutes of Health has launched the first phase of the Neuromod Prize, a $9.8 million competition to accelerate the development of neuromodulation therapies — targeted treatments that adjust nerve activity to improve organ function.

18 Jan 2022

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

A study conducted in two rural Massachusetts jails found that people with opioid use disorder who were incarcerated and received a medication approved to treat opioid use disorder, known as buprenorphine, were less likely to face rearrest and reconviction after release than those who did not receive the medication.

18 Jan 2022

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

In a preliminary study of 106 people with "wet" age-related macular degeneration, Johns Hopkins Medicine researchers report that as many as a third of those with the blinding retinal disease may someday be able to safely stop eye injection therapy without further vision loss.

18 Jan 2022

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Arterial stiffness may be a novel risk factor to be targeted in the prevention and treatment of insulin resistance and dyslipidemia from a young age, a new study published in Hypertension today suggests.

18 Jan 2022

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

In a new study, researchers established a strong approach for deducing public health-relevant epidemiological metrics like relative variant abundance and variant-specific reproduction numbers from wastewater (WW)-derived deep sequenced SARS-CoV-2 genomes.

18 Jan 2022

Medical Condition News

Independent drug action responsible for greater clinical efficacy of combination cancer therapies

New therapies for AIRDs can reduce the harmful side-effects caused by conventional treatments

Antibody combination produces a synergistic response in difficult-to-treat pediatric cancers

Research reveals the impact of COVID-19 on youth with ADHD

Partial bone marrow transplant can dramatically improve survival of mice with cystic fibrosis

Machine learning model identifies new risk genes for motor neurone disease

Rare genetic variants may raise risk of fatal arrhythmias in patients with less advanced coronary artery disease

Research provides new insights on memory loss in Alzheimer's disease

New MRI technique could pave the way to quicker assessment of multiple sclerosis

New pathways responsible for hepatocellular carcinoma identified

Subcutaneous nanotherapy can make immunomodulation more effective in people with type 1 diabetes

Risk factors affect cardiovascular disease risk even in patients with no coronary artery calcium

NIH launches first phase of the Neuromod Prize to develop new neuromodulation therapies

In-jail buprenorphine treatment for opioid use disorder may reduce rearrest and reconviction

Study: Nearly 30% of people with blinding retinal disease can safely stop eye injection therapy

Arterial stiffness in adolescence may be a causal risk factor for insulin resistance and dyslipidemia

Wastewater-based epidemiology to predict emerging new SARS-CoV-2 variants

Chinese scientists reveal key role of lysosome cell death regulator in lung tumor survival

ACP guidelines: Uncomplicated diverticulitis can be treated in an outpatient setting without antibiotics

New blood test for glioblastoma diagnosis may soon be a reality

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News